A Study of GC012F in Patients With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT06235229 · RECRUITING
Trial details
- NCT number
- NCT06235229
- Sponsor
- Gracell Biotechnologies (Shanghai) Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-26
- Primary completion
- 2026-03-02
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.